McCann Health today announced the promotion of Medical Director Dan Carucci MD, MSc, PhD to Global Chief Medical Officer. As an esteemed and expert voice in the scientific and medical community, Dr. Carucci will harness his vast knowledge and experience in innovative medicine, practice and delivery to contribute authoritative science to the agency’s clients and businesses.
In this new role, Dr. Carucci will work closely with McCann Health clients’ medical teams to better understand how to address communications challenges and add value to the rapidly evolving field of medical advances. He will build upon his substantial efforts with senior medical executives and leaders at the national and supranational level to advance McCann Health’s contributions to the global health debate.
Internally, Dr. Carucci will expand on his current role providing McCann Health with expert medical advice and guidance to further reinforce the scientific and medical integrity of work and strengthen the agency’s medical capabilities and offerings to clients.
This appointment goes hand in hand with the steady and continued growth of the McCann Health discipline and the agency’s status as one of the world’s most awarded global healthcare communications networks.
Since joining McCann Health in February 2018, Dr. Carucci has been a fixture across nearly all aspects of the business, driving scientific and medical excellence through an expanded and invigorated scientific community. During the Covid-19 pandemic, Dr. Carucci has become a guiding light for employees and clients, dispatching weekly reports on global data updates, as well as therapeutic and vaccine developments.
He has provided adept guidance for clients and internal groups alike, consulting across businesses and agencies within McCann Health, McCann Worldgroup and IPG in managing the pandemic.
“Dan has deep global medical experience, a vast science research background and an incredibly impressive pedigree,” said John Cahill, Global Chief Executive Officer, McCann Health. “It’s never been more important for our work to be grounded in science and for clients to trust that they have an agency partner on the team who not only understands their products but also has intimate knowledge of how they are used to benefit the global community.”
“In this Covid-19-dominated time, health came to the forefront of society’s mind like never before,” said Bill Kolb, Chairman and CEO, McCann Worldgroup. “The urgency of the Coronavirus crisis has refocused the attention of every marketing company working within the global healthcare environment. With this appointment, Dr. Carucci’s credentials and experience will be harnessed and maximized across our global network to the benefit of all of our brands and businesses.”
“I am so fortunate to be working at an agency with the vision and understanding that truth in science and medicine is fundamental to health communications,” said Dr. Carucci. “I look forward to working with our many dedicated and talented scientists, physicians, and medical professionals, and with our strategy and creative teams to help guide our clients, public and private, to ensure the impact their work is meant to achieve.”
Dr. Carucci is a physician and molecular biologist with over 30 years of experience in cutting-edge science, managing large and complex health programs, innovative vaccine development, organizational leadership and global public health. As a research physician with the US Navy, he led ground-breaking programs in genomics and proteomics, and next-generation vaccine development against malaria.
After retiring from the Navy with the rank of Captain after 20 years active service, he was appointed as the first Director of the Grand Challenges in Global Health Initiative, a $200 million program for the Bill & Melinda Gates Foundation. As Vice President of Global Health at the United Nations Foundation, Dr. Carucci served on the board of the Global Fund to Fight AIDS, TB and Malaria. He also is the co-creator of one of the most creatively awarded health campaigns in history, The Immunity Charm.
Dr. Carucci received his Medical Degree from the University of Virginia, School of Medicine; and a Master of Science in Clinical Tropical Medicine and a Doctor of Philosophy from the London School of Hygiene & Tropical Medicine. He has published more than 80 peer reviewed papers in high impact journals such as Nature and Science, and holds two U.S. patents for vaccine technologies. He chairs a Scientific Advisory Group for the NIH extramural programs, is a Board Member of Grand Challenges Canada, and is a former Board Member of the Jane Goodall Institute.
Reel 360 wishes Dr. Carucci the best of luck in his new role.